María del Rosario
García Campelo
![Foto de María del Rosario](/img/nophoto.png)
![Foto de University Hospital of Lausanne](/img/noimage_org.png)
University Hospital of Lausanne
Lausana, SuizaPublicacións en colaboración con investigadores/as de University Hospital of Lausanne (4)
2024
-
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Annals of Oncology, Vol. 35, Núm. 1, pp. 66-76
2023
-
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
Nature Reviews Clinical Oncology, Vol. 20, Núm. 10, pp. 664-677
2022
-
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial
Annals of Oncology, Vol. 33, Núm. 2, pp. 181-192